Janet Napolitano insider trades: Vir Biotechnology (VIR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Janet reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | VIR | ↓ Sell | 3,200 | $9.45 | $30K | Direct | Jun 2, 2026 (1d) |
| Jun 13, 2025 | ZM | ↓ Sell | 2,617 | $76.78 | $201K | Direct | Jun 13, 2025 (0d) |
| Jun 2, 2025 | VIR | ↓ Sell | 3,200 | $5.05 | $16K | Direct | Jun 2, 2025 (0d) |
| Oct 9, 2024 | ZM | ↓ Sell | 4,477 | $69.39 | $311K | Direct | Oct 11, 2024 (2d) |
| Sep 9, 2024 | VIR | ↓ Sell | 12,190 | $7.80 | $95K | Direct | Sep 10, 2024 (1d) |
| Nov 30, 2021 | VIR | ↓ Sell | 1,435 | $46.25 | $66K | Direct | Dec 2, 2021 (2d) |
| Aug 30, 2021 | VIR | ↓ Sell | 1,435 | $51.15 | $73K | Direct | Aug 31, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VIR insiders
Open-market trades in the last 12 months
About Janet Napolitano's insider trades
Janet Napolitano is a director at Vir Biotechnology (VIR). Since Aug 30, 2021, Janet has reported no open-market purchases and 7 sales worth $793K on SEC Form 4. In the last 12 months: 1 sale ($30K).
Their filings also include option exercises (18 filings), grants and awards (15 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VIR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.